How To Tax Multinationals Hiding Behind The Tree? Use The Mighty U.S. Consumer

Apr 21 2014, 10:34am CDT | by

No, not all tax policy ideas come out of Washington, D.C.  Bill (William H.) Parks, a retired finance professor and founder of NRS, Inc., an Idaho-based paddle-sports accessories maker with $30 million plus in annual sales, has been promoting an idea for taxing the profits of multinational corporations that’s borrowed from the states. Simply put, the IRS would determine the share of a company’s earnings taxable in the U.S. based solely on the share of its sales made to U.S. consumers, the biggest spenders in the world. If you buy a new iPhone, you’d raise Apple's U.S. tax bill.  Buy a Galaxy S5 and Samsung would pay the IRS. No more Senate hearings on the aggressive techniques used by Apple, HP or Microsoft to shift profits abroad. No more fights about the location of intellectual property. In the following guest column, the 79-year-old Parks explains his idea for reforming the federal corporate income tax.

Tax Those Fellows Behind The Tree

By Bill Parks

Don’t tax you, don’t tax me
Tax that fellow behind the tree!
—/>/>
Senator Russell B. Long

It’s time to tax “the fellows behind the tree,” those multinational corporations hiding in plain sight from the IRS by claiming to domicile their operations in foreign low-tax jurisdictions. Recent revelations have exposed the pitiful amount these companies pay on their substantial profits. But they are not to blame if we offer them a legal way to avoid taxes. Who among us wouldn’t do the same thing if given the chance?

So how can we get them to pay their fair share? The solution, like tax-avoiding multinationals, may be hiding in plain sight. Over 100 years ago, Wisconsin pioneered a way of assessing taxes on corporate profits known as formulary apportionment. The Wisconsin model examined a combination of assets, payroll and sales within the state to determine a corporation’s state income tax liability. As other states followed Wisconsin’s lead in adopting formulary apportionment, some opted not to tax payroll and assets, wisely not wanting to discourage either. (A Federation of Tax Administrators list of approaches used by each state is here. )

Sales-based formulary apportionment takes for granted the fact that, while companies can move and manipulate payroll and assets, and even exist without them, no company can survive without sales. As the late Wal-Mart founder Sam Walton famously said: “There is only one boss: the customer.” By harnessing the power of the U.S. consumer market through single sales factor formulary apportionment, we can stop subsidizing the export of jobs and profits and stop discriminating against domestic companies in favor of the multinationals.

Single sales factor formulary apportionment is a territorial system, which means it taxes only domestic activities. In this way, it is simpler and more effective than a universal system, such as our current one, which attempts, and often fails, to tax the world-wide business activities of U.S. corporations. Because it is based on sales, not payroll or assets, it is a difficult system to game; companies can easily move certain business operations and assets out of the U.S., but few, if any, would be willing to give up sales to the world’s most powerful consumer market.

By taxing only the proportion of companies’ overall profits that comes from U.S. sales, we could greatly simplify the tax code and drastically reduce opportunities for system-gaming. This would also level the playing field for smaller domestic firms that typically pay far higher rates today than their multinational competitors. And by taxing the sales of foreign firms that profit from the U.S. market in the same way as domestic firms, it would improve the global competitiveness of U.S. companies while broadening the tax base. This broader tax base would introduce new possibilities for economic stimulus such as reducing the overall corporate tax rate, paying down the debt and reducing deficits, or investing in infrastructure and education.

Of course, there are aspects of single sales factor formulary apportionment that will concern both liberals and conservatives, but these concerns are easily allayed. Liberals worry that a territorial system would drive more corporations to avoid taxes by moving operations abroad, but the single sales factor eliminates that danger by leveraging the power of the U.S. consumer market, which virtually no company would willingly forsake. Furthermore, because it would broaden the base and raise revenues, this system could make more money available for supporting liberal priorities.

Some conservatives want to unfetter U.S. companies by doing away with corporate taxes altogether. But if reducing deficits and paying down the debt are serious priorities, shutting down a key revenue stream is unrealistic. Single sales formulary apportionment can raise revenues for debt and deficit reduction while making U.S. companies more globally competitive.

Today, U.S. companies pay taxes on their U.S. and foreign activities (not really, those taxes on foreign activities are deferred until repatriated, i.e. never), while many foreign corporations pay no U.S. taxes. The single sales factor would eliminate this disadvantage for U.S.-based companies by taxing the U.S. profits of American and foreign firms at the same rate while leaving U.S. companies’ profits abroad untouched. In addition, a broader tax base could make it possible to lower the overall rate, reducing the tax burden for many U.S. businesses.

Fairly implemented, a territorial system based on single sales factor formulary apportionment would benefit U.S businesses and the economy. It would improve American competitiveness in the global marketplace while raising much-needed revenue for economic improvement. Its simplicity and transparency would not only help prevent system-gaming by which many companies avoid paying their share today, it would also make compliance far less onerous for U.S. companies. And because it would tax only profits on sales, it would do all of this without hindering new business growth.

Ultimately, “the fellow behind the tree” may find himself compelled to come out of hiding.

Bill (William H.) Parks founded Northwest River Supplies with a $2,000 investment in 1972 to see if he could apply what he was teaching as a professor of business and finance. NRS, Inc., in which Parks retains a controlling stake, now has annual sales in excess of $30 million.

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

2014 Mac Mini Achieves Low Upgradability Score from iFixit
2014 Mac Mini Achieves Low Upgradability Score from iFixit
The new Mac Mini scores only 6 out of 10 points with respect to upgradability
 
 
Apple Pay being Released with iOS 8.1
Apple Pay being Released with iOS 8.1
The service of Apple Pay has been launched with the introduction of the iOS upgrade
 
 
Apple On Track To Sell 62 Million iPhones
Apple On Track To Sell 62 Million iPhones
Analysts say that growth will set new records this quarter
 
 
Apple’s Earnings Coming From In-App Purchases
Apple’s Earnings Coming From In-App Purchases
Apple believes the majority of Apple Pay income will come from Apps
 
 
 

Latest from the Network

Keira Knightley was 'a goody two-shoes'
Keira Knightley was ''a goody two-shoes'' when she was younger. The 29-year-old actress claims she was a ''boring'' well-behaved child and never skipped school because she didn't want to upset her parents or teachers....
Read more on Celebrity Balla
 
Kat Dennings is in love with Kim Kardashian
Kat Dennings thinks Kim Kardashian's butt is ''amazing.'' The '2 Broke Girls' actress was ''very nervous'' when the 'Keeping Up with the Kardashians' star filmed a cameo for the show's 80th episode and was too shy to...
Read more on Celebrity Balla
 
Taylor Swift doesn't 'need some guy' for inspiration
Taylor Swift is ''figuring out how to cope'' with life on her own. The 'Shake It Off' hitmaker hopes her upcoming album, '1989,' will prove she doesn't ''need some guy'' to help her ''make a great record'' or to feel...
Read more on Celebrity Balla
 
Sarah Hyland is 'great'
Sarah Hyland says she is ''great'' after obtaining a restraining order against her ex-boyfriend. The 'Modern Family' star is happy to be focusing on her career again after a judge recently granted her a three-year...
Read more on Celebrity Balla
 
India re-elected to UNHRC for two years
United Nations, Oct 21 (IANS) India was Tuesday re-elected to the United Nations Human Rights Council (UNHRC) for the term 2015-2017 in a keenly contested election in the UN General Assembly in New York. Other...
Read more on Politics Balla
 
Spanish nurse cured of Ebola
Madrid, Oct 21 (Xinhua) Spanish nursing auxiliary Teresa Romero was pronounced cured of the Ebola virus disease according to World Health Organisation (WHO) guidelines after the results of a second test confirmed...
Read more on Business Balla
 
Gurdwara closed in Belgium
Brussels, Oct 21 (IANS) The mayor of the town of Vilvoorde in Belgium, Hans Bonte, has ordered the closure of the local gurdwara, Guru Nanak Sahib, for one month. Belgian media Tuesday charged that the Sikh temple "...
Read more on Politics Balla
 
Air strikes kill 28 militants in Pakistan
Islamabad, Oct 21 (IANS) At least 28 militants were killed when the Pakistani army launched an air strike in the country's northwest tribal town of Datta Khel Tuesday, military said. In a statement, Inter Services...
Read more on Politics Balla
 
Report reveals large-scale torture in China's 'Black Jails'
Beijing, Oct 21 (IANS/EFE) The use of hotels and factories as clandestine prisons where thousands of people -- mostly women -- are tortured to prevent their complaints against the government from coming to light has...
Read more on Politics Balla
 
Clinical trials of Ebola vaccine start Nov 1 in Switzerland
Geneva, Oct 21 (IANS/EFE) The World Health Organisation (WHO) announced Tuesday that it will begin clinical trials Nov 1 in Switzerland of one of the two anti-Ebola vaccines currently under development. WHO Assistant...
Read more on Business Balla